Molecular Pharmaceutics

Molecular Pharmaceutics is a peer-reviewed scientific journal, published since 2004 by the American Chemical Society. MP is currently indexed in: Chemical Abstracts Service (CAS), SCOPUS, EBSCOhost, British Library, PubMed, CABI, Web of Science, Proquest and SwetsWise. The current Editor is Gordon L. Amidon. Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Theoretical and experimental peer-reviewed communications, full-length research papers, brief articles, and critical reviews are welcomed. Molecular Pharmaceutics publishes Reviews, Articles, Brief Articles and Communications. MP has an Impact Factor of 5.400 as reported by the 2010 Journal Citation Reports by Thomson Reuters. The proper

Publisher
American Chemical Society
Country
United States
History
2004-present
Website
http://pubs.acs.org/journal/mpohbp
Impact factor
5.400 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Why a certain plant virus is so powerful at fighting cancer

A plant virus that infects legumes, called cowpea mosaic virus, has a special power that you may not have known about: when injected into a tumor, it triggers the immune system to treat the cancer—even metastatic cancer—and ...

Medications

Toward painless oral insulin administration

Researchers from Kumamoto University, Japan have found that DNP peptide, a small intestine-permeable cyclic peptide originally used as an insulin additive to improve absorption into the small intestinal, lowers blood glucose ...

Diseases, Conditions, Syndromes

NIST clarifies structure of prospective vaccine for respiratory virus

No approved vaccine exists for RSV, a life-threatening virus that attacks the respiratory system. State-of-the-art neutron and X-ray scattering performed at the National Institute of Standards and Technology (NIST) may bring ...

page 1 from 4